Learn More
Medchemexpress LLC EG01377 dihydrochloride | 2749438-61-5 | 99.0% | 659.60 | 1 ML

Supplier: Medchemexpress LLC HY112151A10MM/1ML
EG01377 dihydrochloride is a potent, bioavailable, and selective inhibitor of neuropilin-1 (NRP1), with a Kd of 1.32 μM, and IC50s of 609 nM for both NRP1-a1 and NRP1-b1. It exhibits antiangiogenic, antimigratory, and antitumor effects.
- Inhibits vascular endothelial growth factor A (VEGF-A) stimulated tyrosine phosphorylation of VEGF-R2/KDR.
- Reduces HUVEC cell migration in response to VEGFA.
- Can delay VEGF-induced wound closure.
- Reduces network area, length, and branching points.
- Reduces VEGF-induced angiogenesis.
- Reduces A375P (malignant melanoma) spheroid outgrowth in combination with VEGFA.
- Blocks the production of transforming growth factor beta (TGFβ) by Nrp1+ regulatory T-cell SMAD3/AKT (Tregs) in the presence of tumor cell-derived factors.
- Exhibits an encouraging half-life sufficient to sustain once per day dosing in mice.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.